AngioDynamics (ANGO) Tops Q3 EPS by 4c, Offers Guidance

AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $71.2 million versus the consensus estimate of $68.95 million.

GUIDANCE:

AngioDynamics sees FY2021 EPS of $0.04-$0.06, versus the consensus of $0.01. AngioDynamics sees FY2021 revenue of $285-288 million, versus the consensus of $283.5 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• RBC Capital Starts Tabcorp Holdings (TAH:AU) (TABCF) at Outperform
• BMO Capital Reiterates Market Perform Rating on Axalta Coating Systems (AXTA)